Availability of anticancer biosimilars in 40 countries

Lancet Oncol. 2020 Feb;21(2):197-201. doi: 10.1016/S1470-2045(19)30860-5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Biosimilar Pharmaceuticals*
  • Genome-Wide Association Study
  • Humans
  • Lymphoma*
  • Natural Killer T-Cells*
  • Risk Factors

Substances

  • Biosimilar Pharmaceuticals